Post by Ariadne S.

It is gratifying to see GVN and Terumo collaborate to systematically introduce microwave ablation technology into the minimally invasive treatment of thyroid and breast nodules. Of particular note is the participation of 49 medical insurance institutions, indicating a clear demand from the payer side for minimally invasive, day-care, and function-preserving treatments. We hope this four-pronged approach of medical insurance + manufacturer + hospital + network can serve as a model for other specialties